Home Healthcare IT Cancer Stem Cell Market

Cancer Stem Cell Market Size, Share & Trends Analysis Report By Mode of Action (Targeted Cancerous Stem Cells (CSCs), Stem Cell-based Cancer Therapy), By Cancer Types (Breast, Blood, Lung, Brain, Colorectal, Pancreatic, Bladder, Liver, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 23, 2025 | Author: Debashree B | Format: | Report Code: SRHI20DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Regulatory Framework
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  7. ESG Trends
  8. Global Cancer Stem Cell Market Size Analysis
    1. Global Cancer Stem Cell Market Introduction
    2. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Targeted Cancerous Stem Cells (CSCs)
        1. By Value
        2. By Anti-CSC Therapeutics
          1. By Anti-CSC Therapeutics By Value
          2. Pathway Inhibitors
            1. Pathway Inhibitors By Value
          3. Immuno-evasion & Targeting Tumor Microenvironment
            1. Immuno-evasion & Targeting Tumor Microenvironment By Value
          4. Nanoparticle-based Therapies
            1. Nanoparticle-based Therapies By Value
          5. Others
            1. Others By Value
        3. By Products
          1. By Products By Value
          2. Cell-Culturing
            1. Cell-Culturing By Value
          3. Cell-Separation
            1. Cell-Separation By Value
          4. Cell Analysis
            1. Cell Analysis By Value
          5. Molecular Analysis
            1. Molecular Analysis By Value
          6. Others
            1. Others By Value
      3. Stem Cell-based Cancer Therapy
        1. By Value
        2. Autologous SC Transplant
          1. Autologous SC Transplant By Value
        3. Allogeneic SC Transplant
          1. Allogeneic SC Transplant By Value
    3. By Cancer Types
      1. Introduction
        1. Cancer Types By Value
      2. Breast
        1. By Value
      3. Blood
        1. By Value
      4. Lung
        1. By Value
      5. Brain
        1. By Value
      6. Colorectal
        1. By Value
      7. Pancreatic
        1. By Value
      8. Bladder
        1. By Value
      9. Liver
        1. By Value
      10. Others
        1. By Value
  9. North America Market Analysis
    1. Introduction
    2. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Targeted Cancerous Stem Cells (CSCs)
        1. By Value
        2. By Anti-CSC Therapeutics
          1. By Anti-CSC Therapeutics By Value
          2. Pathway Inhibitors
            1. Pathway Inhibitors By Value
          3. Immuno-evasion & Targeting Tumor Microenvironment
            1. Immuno-evasion & Targeting Tumor Microenvironment By Value
          4. Nanoparticle-based Therapies
            1. Nanoparticle-based Therapies By Value
          5. Others
            1. Others By Value
        3. By Products
          1. By Products By Value
          2. Cell-Culturing
            1. Cell-Culturing By Value
          3. Cell-Separation
            1. Cell-Separation By Value
          4. Cell Analysis
            1. Cell Analysis By Value
          5. Molecular Analysis
            1. Molecular Analysis By Value
          6. Others
            1. Others By Value
      3. Stem Cell-based Cancer Therapy
        1. By Value
        2. Autologous SC Transplant
          1. Autologous SC Transplant By Value
        3. Allogeneic SC Transplant
          1. Allogeneic SC Transplant By Value
    3. By Cancer Types
      1. Introduction
        1. Cancer Types By Value
      2. Breast
        1. By Value
      3. Blood
        1. By Value
      4. Lung
        1. By Value
      5. Brain
        1. By Value
      6. Colorectal
        1. By Value
      7. Pancreatic
        1. By Value
      8. Bladder
        1. By Value
      9. Liver
        1. By Value
      10. Others
        1. By Value
    4. U.S.
      1. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Targeted Cancerous Stem Cells (CSCs)
          1. By Value
          2. By Anti-CSC Therapeutics
            1. By Anti-CSC Therapeutics By Value
            2. Pathway Inhibitors
              1. Pathway Inhibitors By Value
            3. Immuno-evasion & Targeting Tumor Microenvironment
              1. Immuno-evasion & Targeting Tumor Microenvironment By Value
            4. Nanoparticle-based Therapies
              1. Nanoparticle-based Therapies By Value
            5. Others
              1. Others By Value
          3. By Products
            1. By Products By Value
            2. Cell-Culturing
              1. Cell-Culturing By Value
            3. Cell-Separation
              1. Cell-Separation By Value
            4. Cell Analysis
              1. Cell Analysis By Value
            5. Molecular Analysis
              1. Molecular Analysis By Value
            6. Others
              1. Others By Value
        3. Stem Cell-based Cancer Therapy
          1. By Value
          2. Autologous SC Transplant
            1. Autologous SC Transplant By Value
          3. Allogeneic SC Transplant
            1. Allogeneic SC Transplant By Value
      2. By Cancer Types
        1. Introduction
          1. Cancer Types By Value
        2. Breast
          1. By Value
        3. Blood
          1. By Value
        4. Lung
          1. By Value
        5. Brain
          1. By Value
        6. Colorectal
          1. By Value
        7. Pancreatic
          1. By Value
        8. Bladder
          1. By Value
        9. Liver
          1. By Value
        10. Others
          1. By Value
    5. Canada
  10. Europe Market Analysis
    1. Introduction
    2. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Targeted Cancerous Stem Cells (CSCs)
        1. By Value
        2. By Anti-CSC Therapeutics
          1. By Anti-CSC Therapeutics By Value
          2. Pathway Inhibitors
            1. Pathway Inhibitors By Value
          3. Immuno-evasion & Targeting Tumor Microenvironment
            1. Immuno-evasion & Targeting Tumor Microenvironment By Value
          4. Nanoparticle-based Therapies
            1. Nanoparticle-based Therapies By Value
          5. Others
            1. Others By Value
        3. By Products
          1. By Products By Value
          2. Cell-Culturing
            1. Cell-Culturing By Value
          3. Cell-Separation
            1. Cell-Separation By Value
          4. Cell Analysis
            1. Cell Analysis By Value
          5. Molecular Analysis
            1. Molecular Analysis By Value
          6. Others
            1. Others By Value
      3. Stem Cell-based Cancer Therapy
        1. By Value
        2. Autologous SC Transplant
          1. Autologous SC Transplant By Value
        3. Allogeneic SC Transplant
          1. Allogeneic SC Transplant By Value
    3. By Cancer Types
      1. Introduction
        1. Cancer Types By Value
      2. Breast
        1. By Value
      3. Blood
        1. By Value
      4. Lung
        1. By Value
      5. Brain
        1. By Value
      6. Colorectal
        1. By Value
      7. Pancreatic
        1. By Value
      8. Bladder
        1. By Value
      9. Liver
        1. By Value
      10. Others
        1. By Value
    4. U.K.
      1. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Targeted Cancerous Stem Cells (CSCs)
          1. By Value
          2. By Anti-CSC Therapeutics
            1. By Anti-CSC Therapeutics By Value
            2. Pathway Inhibitors
              1. Pathway Inhibitors By Value
            3. Immuno-evasion & Targeting Tumor Microenvironment
              1. Immuno-evasion & Targeting Tumor Microenvironment By Value
            4. Nanoparticle-based Therapies
              1. Nanoparticle-based Therapies By Value
            5. Others
              1. Others By Value
          3. By Products
            1. By Products By Value
            2. Cell-Culturing
              1. Cell-Culturing By Value
            3. Cell-Separation
              1. Cell-Separation By Value
            4. Cell Analysis
              1. Cell Analysis By Value
            5. Molecular Analysis
              1. Molecular Analysis By Value
            6. Others
              1. Others By Value
        3. Stem Cell-based Cancer Therapy
          1. By Value
          2. Autologous SC Transplant
            1. Autologous SC Transplant By Value
          3. Allogeneic SC Transplant
            1. Allogeneic SC Transplant By Value
      2. By Cancer Types
        1. Introduction
          1. Cancer Types By Value
        2. Breast
          1. By Value
        3. Blood
          1. By Value
        4. Lung
          1. By Value
        5. Brain
          1. By Value
        6. Colorectal
          1. By Value
        7. Pancreatic
          1. By Value
        8. Bladder
          1. By Value
        9. Liver
          1. By Value
        10. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
  11. APAC Market Analysis
    1. Introduction
    2. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Targeted Cancerous Stem Cells (CSCs)
        1. By Value
        2. By Anti-CSC Therapeutics
          1. By Anti-CSC Therapeutics By Value
          2. Pathway Inhibitors
            1. Pathway Inhibitors By Value
          3. Immuno-evasion & Targeting Tumor Microenvironment
            1. Immuno-evasion & Targeting Tumor Microenvironment By Value
          4. Nanoparticle-based Therapies
            1. Nanoparticle-based Therapies By Value
          5. Others
            1. Others By Value
        3. By Products
          1. By Products By Value
          2. Cell-Culturing
            1. Cell-Culturing By Value
          3. Cell-Separation
            1. Cell-Separation By Value
          4. Cell Analysis
            1. Cell Analysis By Value
          5. Molecular Analysis
            1. Molecular Analysis By Value
          6. Others
            1. Others By Value
      3. Stem Cell-based Cancer Therapy
        1. By Value
        2. Autologous SC Transplant
          1. Autologous SC Transplant By Value
        3. Allogeneic SC Transplant
          1. Allogeneic SC Transplant By Value
    3. By Cancer Types
      1. Introduction
        1. Cancer Types By Value
      2. Breast
        1. By Value
      3. Blood
        1. By Value
      4. Lung
        1. By Value
      5. Brain
        1. By Value
      6. Colorectal
        1. By Value
      7. Pancreatic
        1. By Value
      8. Bladder
        1. By Value
      9. Liver
        1. By Value
      10. Others
        1. By Value
    4. China
      1. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Targeted Cancerous Stem Cells (CSCs)
          1. By Value
          2. By Anti-CSC Therapeutics
            1. By Anti-CSC Therapeutics By Value
            2. Pathway Inhibitors
              1. Pathway Inhibitors By Value
            3. Immuno-evasion & Targeting Tumor Microenvironment
              1. Immuno-evasion & Targeting Tumor Microenvironment By Value
            4. Nanoparticle-based Therapies
              1. Nanoparticle-based Therapies By Value
            5. Others
              1. Others By Value
          3. By Products
            1. By Products By Value
            2. Cell-Culturing
              1. Cell-Culturing By Value
            3. Cell-Separation
              1. Cell-Separation By Value
            4. Cell Analysis
              1. Cell Analysis By Value
            5. Molecular Analysis
              1. Molecular Analysis By Value
            6. Others
              1. Others By Value
        3. Stem Cell-based Cancer Therapy
          1. By Value
          2. Autologous SC Transplant
            1. Autologous SC Transplant By Value
          3. Allogeneic SC Transplant
            1. Allogeneic SC Transplant By Value
      2. By Cancer Types
        1. Introduction
          1. Cancer Types By Value
        2. Breast
          1. By Value
        3. Blood
          1. By Value
        4. Lung
          1. By Value
        5. Brain
          1. By Value
        6. Colorectal
          1. By Value
        7. Pancreatic
          1. By Value
        8. Bladder
          1. By Value
        9. Liver
          1. By Value
        10. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
  12. Middle East and Africa Market Analysis
    1. Introduction
    2. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Targeted Cancerous Stem Cells (CSCs)
        1. By Value
        2. By Anti-CSC Therapeutics
          1. By Anti-CSC Therapeutics By Value
          2. Pathway Inhibitors
            1. Pathway Inhibitors By Value
          3. Immuno-evasion & Targeting Tumor Microenvironment
            1. Immuno-evasion & Targeting Tumor Microenvironment By Value
          4. Nanoparticle-based Therapies
            1. Nanoparticle-based Therapies By Value
          5. Others
            1. Others By Value
        3. By Products
          1. By Products By Value
          2. Cell-Culturing
            1. Cell-Culturing By Value
          3. Cell-Separation
            1. Cell-Separation By Value
          4. Cell Analysis
            1. Cell Analysis By Value
          5. Molecular Analysis
            1. Molecular Analysis By Value
          6. Others
            1. Others By Value
      3. Stem Cell-based Cancer Therapy
        1. By Value
        2. Autologous SC Transplant
          1. Autologous SC Transplant By Value
        3. Allogeneic SC Transplant
          1. Allogeneic SC Transplant By Value
    3. By Cancer Types
      1. Introduction
        1. Cancer Types By Value
      2. Breast
        1. By Value
      3. Blood
        1. By Value
      4. Lung
        1. By Value
      5. Brain
        1. By Value
      6. Colorectal
        1. By Value
      7. Pancreatic
        1. By Value
      8. Bladder
        1. By Value
      9. Liver
        1. By Value
      10. Others
        1. By Value
    4. UAE
      1. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Targeted Cancerous Stem Cells (CSCs)
          1. By Value
          2. By Anti-CSC Therapeutics
            1. By Anti-CSC Therapeutics By Value
            2. Pathway Inhibitors
              1. Pathway Inhibitors By Value
            3. Immuno-evasion & Targeting Tumor Microenvironment
              1. Immuno-evasion & Targeting Tumor Microenvironment By Value
            4. Nanoparticle-based Therapies
              1. Nanoparticle-based Therapies By Value
            5. Others
              1. Others By Value
          3. By Products
            1. By Products By Value
            2. Cell-Culturing
              1. Cell-Culturing By Value
            3. Cell-Separation
              1. Cell-Separation By Value
            4. Cell Analysis
              1. Cell Analysis By Value
            5. Molecular Analysis
              1. Molecular Analysis By Value
            6. Others
              1. Others By Value
        3. Stem Cell-based Cancer Therapy
          1. By Value
          2. Autologous SC Transplant
            1. Autologous SC Transplant By Value
          3. Allogeneic SC Transplant
            1. Allogeneic SC Transplant By Value
      2. By Cancer Types
        1. Introduction
          1. Cancer Types By Value
        2. Breast
          1. By Value
        3. Blood
          1. By Value
        4. Lung
          1. By Value
        5. Brain
          1. By Value
        6. Colorectal
          1. By Value
        7. Pancreatic
          1. By Value
        8. Bladder
          1. By Value
        9. Liver
          1. By Value
        10. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
  13. LATAM Market Analysis
    1. Introduction
    2. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Targeted Cancerous Stem Cells (CSCs)
        1. By Value
        2. By Anti-CSC Therapeutics
          1. By Anti-CSC Therapeutics By Value
          2. Pathway Inhibitors
            1. Pathway Inhibitors By Value
          3. Immuno-evasion & Targeting Tumor Microenvironment
            1. Immuno-evasion & Targeting Tumor Microenvironment By Value
          4. Nanoparticle-based Therapies
            1. Nanoparticle-based Therapies By Value
          5. Others
            1. Others By Value
        3. By Products
          1. By Products By Value
          2. Cell-Culturing
            1. Cell-Culturing By Value
          3. Cell-Separation
            1. Cell-Separation By Value
          4. Cell Analysis
            1. Cell Analysis By Value
          5. Molecular Analysis
            1. Molecular Analysis By Value
          6. Others
            1. Others By Value
      3. Stem Cell-based Cancer Therapy
        1. By Value
        2. Autologous SC Transplant
          1. Autologous SC Transplant By Value
        3. Allogeneic SC Transplant
          1. Allogeneic SC Transplant By Value
    3. By Cancer Types
      1. Introduction
        1. Cancer Types By Value
      2. Breast
        1. By Value
      3. Blood
        1. By Value
      4. Lung
        1. By Value
      5. Brain
        1. By Value
      6. Colorectal
        1. By Value
      7. Pancreatic
        1. By Value
      8. Bladder
        1. By Value
      9. Liver
        1. By Value
      10. Others
        1. By Value
    4. Brazil
      1. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Targeted Cancerous Stem Cells (CSCs)
          1. By Value
          2. By Anti-CSC Therapeutics
            1. By Anti-CSC Therapeutics By Value
            2. Pathway Inhibitors
              1. Pathway Inhibitors By Value
            3. Immuno-evasion & Targeting Tumor Microenvironment
              1. Immuno-evasion & Targeting Tumor Microenvironment By Value
            4. Nanoparticle-based Therapies
              1. Nanoparticle-based Therapies By Value
            5. Others
              1. Others By Value
          3. By Products
            1. By Products By Value
            2. Cell-Culturing
              1. Cell-Culturing By Value
            3. Cell-Separation
              1. Cell-Separation By Value
            4. Cell Analysis
              1. Cell Analysis By Value
            5. Molecular Analysis
              1. Molecular Analysis By Value
            6. Others
              1. Others By Value
        3. Stem Cell-based Cancer Therapy
          1. By Value
          2. Autologous SC Transplant
            1. Autologous SC Transplant By Value
          3. Allogeneic SC Transplant
            1. Allogeneic SC Transplant By Value
      2. By Cancer Types
        1. Introduction
          1. Cancer Types By Value
        2. Breast
          1. By Value
        3. Blood
          1. By Value
        4. Lung
          1. By Value
        5. Brain
          1. By Value
        6. Colorectal
          1. By Value
        7. Pancreatic
          1. By Value
        8. Bladder
          1. By Value
        9. Liver
          1. By Value
        10. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
  14. Competitive Landscape
    1. Cancer Stem Cell Market Share By Players
    2. M&A Agreements & Collaboration Analysis
  15. Market Players Assessment
    1. Thermo Fisher Scientific, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AbbVie, Inc.
    3. Merck KGaA
    4. Bionomics
    5. Lonza
    6. The Menarini Group
    7. Miltenyi Biotec
    8. PromoCell GmbH
    9. MacroGenics, Inc.
    10. OncoMed Pharmaceuticals, Inc.
    11. FUJIFILM Irvine Scientific
    12. STEMCELL Technologies
    13. Sino Biological, Inc.
    14. Lineage Cell Therapeutics, Inc.
    15. Celprogen Inc.
    16. AstraZeneca
    17. Gilead Sciences
    18. Bristol Myers Squibb
    19. FibroBiologics
    20. Others
  16. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  17. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  18. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.